Governor Mocks Cimahi Mayor Over Illegal Drug Crackdown: 'Are You Afraid?'
Translated from Indonesian, summarized and contextualized by DistantNews.
At a glance
- West Java Governor Dedi Mulyadi urged Cimahi Mayor Ngatiyana to take firm action against the circulation of illegal drugs, particularly tramadol.
- Mulyadi questioned the lack of decisive action, suggesting that the mayor's military background should empower him to confront the issue, which is reportedly protected by certain groups.
- The governor raised concerns during a corruption prevention coordination meeting, highlighting citizen complaints about tramadol availability in Cimahi.
West Java Governor Dedi Mulyadi has directly challenged Cimahi Mayor Ngatiyana to eradicate the rampant circulation of illegal drugs in the city. During a coordination meeting on corruption prevention, Mulyadi pointedly questioned the mayor's inaction, particularly concerning the alleged widespread availability of tramadol.
"How is this possible, so much tramadol is circulating. A resident even became a victim. There are many NGOs, so no one dares to take action. Surely Mr. Mayor, with your military background, you are not afraid to act?" Mulyadi stated, addressing Ngatiyana. The governor implied that the drug trade might be operating under the protection of certain non-governmental organizations.
Mulyadi's remarks came as he arrived at the meeting in Cimahi, where he was greeted by regional heads. He immediately engaged Ngatiyana, urging him to confront the issue head-on. The governor's direct approach underscores a perceived lack of decisive law enforcement against drug trafficking in the area, despite the mayor's own military past.
How is this possible, so much tramadol is circulating. A resident even became a victim. There are many NGOs, so no one dares to take action. Surely Mr. Mayor, with your military background, you are not afraid to act?
Originally published by Republika in Indonesian. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.